309597
Young adults' tobacco product risk perceptions
Methods: We examined responses to risk perception measures on the 2011 National Young Adult Health Survey, the first national cell phone RDD survey of young adults (ages 18-34)(n=2871).
Results: The majority of respondents (57.8%) believed that e-cigarettes were less risky than cigarettes (although 11.4% were unsure), followed by hookah (24.5%), cigars (13.9%), snus (10%), smokeless tobacco (7.1%) and menthol cigarettes (2.5%). More respondents were “unsure” about snus (8.8%) versus smokeless tobacco (2.8%). For e-cigarettes and hookah, the “less risky” belief was more prevalent among males, younger young adults (18-24), those with more education, and those who had ever used the products (over 20 percentage points higher) versus never users. Between 22-33% of respondents believed that SLT, snus, menthol cigarettes and cigars were more risky than cigarettes, a belief more prevalent among males and younger young adults. The differences in prevalence of this “more risky” belief between current users and non-users of these products were small (i.e., 5-6 percentage points) and insignificant.
Conclusion: Perceptions that tobacco products are “less risky” than cigarettes vary widely by product type. While “less risky” perceptions may motivate product use, perceptions that products are “more risky” may not dissuade people from their use.
Learning Areas:
Public health or related researchSocial and behavioral sciences
Learning Objectives:
Describe young adults’ risk perceptions of various tobacco products relative to cigarettes.
Describe trends and factors associated with varying tobacco product risk perceptions.
Keyword(s): Tobacco Control, Tobacco Use
Qualified on the content I am responsible for because: Olivia Wackowski, PhD, MPH has worked in the area of tobacco control for ten years and has previously delivered presentations and published papers analyzing tobacco survey data and risk perceptions.
Any relevant financial relationships? No
I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.